Discovery of proangiogenic CD44+mesenchymal cancer stem cells in an acute myeloid leukemia patient’s bone marrow
2020 · Journal of Hematology & Oncology · 18 citations
https://doi.org/10.1186/s13045-020-00899-x
J
Jeffrey Xiao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
324
Citations
8
h-index
8
i10-index
Jeffrey Xiao is an academic researcher from Loma Linda University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Immune Cell Function and Interaction & CAR-T cell therapy research. The author has an h-index of 8, co-authored 18 publications.
ORCID: 0000-0002-6252-3320Papers by this author
worksVitamin D activates FBP1 to block the Warburg effect and modulate blast metabolism in acute myeloid leukemia
2022 · Biomarker Research · 12 citations
https://doi.org/10.1186/s40364-022-00367-3
Nutrient-gene therapy as a strategy to enhance CAR T cell function and overcome barriers in the tumor microenvironment
2025 · Journal of Translational Medicine · 4 citations
https://doi.org/10.1186/s12967-025-06606-z
Exploring treatment-driven subclonal evolution of prognostic triple biomarkers: Dual gene fusions and chimeric RNA variants in novel subtypes of acute myeloid leukemia patients with KMT2A rearrangement
2025 · Drug Resistance Updates · 3 citations
https://doi.org/10.1016/j.drup.2024.101199
Targeting DNA helicase CMG complex and NFκB2-driven drug-resistant transcriptional axis to effectively treat KRASG12D-mutated pancreatic cancer
2025 · Experimental Hematology and Oncology · 1 citations
https://doi.org/10.1186/s40164-025-00669-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat